# Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery

Study · id `cardio:ct-nct03271762` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03271762](<https://clinicaltrials.gov/study/NCT03271762>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03271762

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 330 participants.

## Technical summary

Registry record NCT03271762. Randomized; no masking; primary purpose treatment. Start 2018-03-02 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 330 participants (enrolled count; ClinicalTrials.gov record NCT03271762, source copy `cardio:ctgov-nct03271762-2026-11-13`, retrieved 2026-11-18)
- Started: 2018-03-02 (actual) (ClinicalTrials.gov record NCT03271762, source copy `cardio:ctgov-nct03271762-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT03271762, source copy `cardio:ctgov-nct03271762-2026-11-13`, retrieved 2026-11-18)
- Completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT03271762, source copy `cardio:ctgov-nct03271762-2026-11-13`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT03271762, source copy `cardio:ctgov-nct03271762-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03271762-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery
- Acronym: MITRA-HR
- Condition: Mitral Regurgitation
- Intervention (Device): percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW
- Intervention (Procedure): cardiac surgery
- Lead sponsor: Nantes University Hospital
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Nantes University Hospital (`cardio:org-nantes-university-hospital`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)

## Provenance

Content hash: afadf391e57e796225d65682871a2bf7daa4032b49a8b1fbddb442303fe424ae
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
